EUVIMEDEUVIMED entdecken
Crossref

Concentration‐Dependent Reactivity Profiles of a Human Monoclonal Antibody Recognising HLA‐DQB1*04/05/06 and at Reduced Intensities to DQB1*03 Antigens

Tina Meng iD, Ujjwala Singh iD, Naiiry Petrosyan iD, Fred Quiroz iD, Xiaoliang Yao iD, Than Than Han iD, Hsiao-Min Chang iD, Eric Ka-Wai Hui iD, David Suh iD, Vincent Ma iD, Elaina Rybak iD, Quansheng Zhu iD und 6 weitere

HLA · 2026

DOI: 10.1111/tan.70889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, 2026. Verfasst von Tina Meng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Transplant Diagnostics, Thermo Fisher Scientific Inc., West Hills, California, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, HLA-DQ beta-Chains, Epitopes, B-Lymphocyte. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Thermo Fisher Scientific.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Identifying HLA amino acid residues that account for an observed specificity (reactivity profile) is critical for serological categorisation at the B‐cell epitope level. Human monoclonal antibody, LB_DQB0402_A, produced by an individual typed DQA1*03:03 , DQA1*05:05/*05:11 , DQB1*03:01 , DQB1*03:01 against an immuniser typed DQA1*01:02 , DQA1*05:05 , DQB1*03:01 , DQB1*06:02 , reacts strongly to DQB1*04/05/06 single antigen beads (SABs), for which 55R, present in DQB1*04/05/06 alleles, has been previously proposed to be the target eplet. In this study, the antibody was also observed to react with DQB1*03 SABs albeit with reduced intensities and only at antibody concentrations higher than 1 μg/mL. Additional weak reactivities to DQB1*02 SABs were also observed when the concentration was further increased to 10 μg/mL. Different clusters responsible for the three concentration‐dependent reactivity profiles were predicted by AminoAcid3D algorithm, and two (DQB1_46V and DQB1_55R) were verified using engineered variants (EVs) derived from DQA1*02:01 ‐ DQB1*06:01 expressed on cells and immobilised on beads, with bead assay more sensitive than cell assay. However, EVs targeting the third cluster (DQB1_81H) did not impact binding, suggesting 81H is not involved in binding to DQB1*04/05/06 when strong interacting 46V and 55R are present. On the other hand, 81H was predicted to account for the weak interactions with DQB1*02 antigens when neither 46V nor 55R are present. As to DQB1*03 , only 46V and 81H are present, so the reduced signals could be due to the missing 55R. This antibody appears to pivot toward the stronger interacting residues available on different antigens. Although HLA alloantibodies develop and affinity mature against a specific foreign conformation, reactivity spread is expected if another antigen shares the same essential residue/region for specificity (ERS) and similar constituents of an epitope. However, this study demonstrates that reactivities in an in vitro setting can still occur even to antigens, including self, not carrying the same ERS as the immuniser, albeit of a much weaker intensity only observed above certain high antibody concentrations. While the clinical relevance of such observations remains unknown, this level of differentiation impacts the analysis of antigenicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalHLA-DQ beta-ChainsEpitopes, B-LymphocyteHumansAllelesHistocompatibility Testing

Stichwörter der Autor:innen

AminoAcid3D (AA3D)HLAdonor specific antibody (DSA)engineered variantepitope analysisessential regionhuman monoclonal antibodyreactivity profilesingle antigen bead (SAB)

Substanzen

Antibodies, MonoclonalHLA-DQ beta-ChainsHLA-DQB1 antigenEpitopes, B-Lymphocyte

Autor:innen und Institutionen

  • Research and Development, Transplant Diagnostics, Thermo Fisher Scientific Inc., West Hills, California, USA.
  • Software Engineering, Transplant Diagnostics, Thermo Fisher Scientific Inc., West Hills, California, USA.
  • Customer Experience, Transplant Diagnostics, Thermo Fisher Scientific Inc., West Hills, California, USA.
  • Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.

ORCID-Profile: Tina Meng, Ujjwala Singh, Naiiry Petrosyan, Fred Quiroz, Xiaoliang Yao, Than Than Han, Hsiao-Min Chang, Eric Ka-Wai Hui, David Suh, Vincent Ma, Elaina Rybak, Quansheng Zhu, Zhifang Wang, James Jones, Dave Roelen, Cynthia S M Kramer, Sebastiaan Heidt, Dave Lowe

Förderung

  • Thermo Fisher Scientific

Zitieren

APA

Meng, T., Singh, U., Petrosyan, N., Quiroz, F., Yao, X., Han, T. T., Chang, H. M., Hui, E. K., Suh, D., Ma, V., Rybak, E., Zhu, Q., Wang, Z., Jones, J., Roelen, D., Kramer, C. S. M., Heidt, S., & Lowe, D. (2026). Concentration‐Dependent Reactivity Profiles of a Human Monoclonal Antibody Recognising HLA‐DQB1*04/05/06 and at Reduced Intensities to DQB1*03 Antigens. HLA. https://doi.org/10.1111/tan.70889

Vancouver

Meng T, Singh U, Petrosyan N, Quiroz F, Yao X, Han TT, et al. Concentration‐Dependent Reactivity Profiles of a Human Monoclonal Antibody Recognising HLA‐DQB1*04/05/06 and at Reduced Intensities to DQB1*03 Antigens. HLA. 2026. doi:10.1111/tan.70889

BibTeX
@article{Meng2026,
  author = {Meng, Tina and Singh, Ujjwala and Petrosyan, Naiiry and Quiroz, Fred and Yao, Xiaoliang and Han, Than Than and Chang, Hsiao-Min and Hui, Eric Ka-Wai and Suh, David and Ma, Vincent and Rybak, Elaina and Zhu, Quansheng and Wang, Zhifang and Jones, James and Roelen, Dave and Kramer, Cynthia S M and Heidt, Sebastiaan and Lowe, Dave},
  title = {Concentration‐Dependent Reactivity Profiles of a Human Monoclonal Antibody Recognising HLA‐DQB1*04/05/06 and at Reduced Intensities to DQB1*03 Antigens},
  journal = {HLA},
  year = {2026},
  doi = {10.1111/tan.70889}
}
Kostenlos starten →